Literature DB >> 22855009

Recognition of other organ involvement might assist in the differential diagnosis of IgG4-associated sclerosing cholangitis without apparent pancreatic involvement: report of two cases.

Takeshi Nowatari1, Akihiko Kobayashi, Kiyoshi Fukunaga, Tatsuya Oda, Ryoko Sasaki, Nobuhiro Ohkohchi.   

Abstract

IgG4-associated sclerosing cholangitis (IAC) was recently defined as biliary involvement of IgG4-related systemic disease. It is frequently associated with autoimmune pancreatitis, characterized by pancreatic enlargement and irregular narrowing of the pancreatic duct. However, a few cases of IAC with no apparent pancreatic involvement have been described, the characteristics of which may mimic those of cholangiocarcinoma. We report two rare cases of IgG4-associated sclerosing cholangitis at the hepatic hilum, mimicking hilar cholangiocarcinoma. When trying to establish the diagnosis, we should consider other organs that could be involved, such as the pancreas, salivary glands, retroperitoneum, lymph nodes, and kidneys, as well as chronic inflammatory changes. By recognizing these lesions and measuring serum IgG4, IAC can be diagnosed correctly, thereby avoiding unnecessary major surgery for a condition that is treated effectively by steroid therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855009     DOI: 10.1007/s00595-012-0278-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  23 in total

1.  Immunoglobulin G4-associated sclerosing cholangitis mimicking cholangiocarcinoma.

Authors:  D T M Chung; C N Tang; E C H Lai; G P C Yang; M K W Li
Journal:  Hong Kong Med J       Date:  2010-04       Impact factor: 2.227

2.  Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma.

Authors:  Abdul M Oseini; Roongruedee Chaiteerakij; Abdirashid M Shire; Amaar Ghazale; Joseph Kaiya; Catherine D Moser; Ileana Aderca; Teresa A Mettler; Terry M Therneau; Lizhi Zhang; Naoki Takahashi; Suresh T Chari; Lewis R Roberts
Journal:  Hepatology       Date:  2011-08-08       Impact factor: 17.425

3.  Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy.

Authors:  Takayoshi Nishino; Fumitake Toki; Hiroyasu Oyama; Kyoko Shimizu; Keiko Shiratori
Journal:  Intern Med       Date:  2006-05-15       Impact factor: 1.271

4.  Differential diagnosis of stenosing lesions at the hepatic hilus.

Authors:  Jonathan Koea; Andrew Holden; Kai Chau; John McCall
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

5.  An autopsy case of autoimmune pancreatitis.

Authors:  Yohei Kitano; Kakuya Matsumoto; Kenji Chisaka; Masako Imazawa; Kenji Takahashi; Yukiomi Nakade; Mituyoshi Okada; Kazunobu Aso; Kazunori Yokoyama; Masahiro Yamamoto; Masumi Yoshie; Katsuhiro Ogawa; Masakazu Haneda
Journal:  JOP       Date:  2007-09-07

6.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

7.  Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.

Authors:  Hideaki Hamano; Norikazu Arakura; Takashi Muraki; Yayoi Ozaki; Kendo Kiyosawa; Shigeyuki Kawa
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

8.  IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.

Authors:  Moon-Tong Cheung; Irene Lai-Oi Lo
Journal:  ANZ J Surg       Date:  2008-04       Impact factor: 1.872

Review 9.  IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

10.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

Authors:  Amaar Ghazale; Suresh T Chari; Lizhi Zhang; Thomas C Smyrk; Naoki Takahashi; Michael J Levy; Mark D Topazian; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Keith Lindor; Michael B Farnell
Journal:  Gastroenterology       Date:  2007-12-07       Impact factor: 22.682

View more
  2 in total

Review 1.  [Immunoglobulin G4 (IgG4)-related disease. A review of head and neck manifestations].

Authors:  A Agaimy; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

2.  Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case.

Authors:  Atsushi Miki; Yasunaru Sakuma; Hideyuki Ohzawa; Yukihiro Sanada; Hideki Sasanuma; Alan T Lefor; Naohiro Sata; Yoshikazu Yasuda
Journal:  Int Surg       Date:  2015-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.